- 2024-08-20 01:53抑制剂CX-6258 hydrochloride|CX-6258 hydrochloride|1353859-00-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:53抑制剂CX-6258 hydrochloride|CX-6258 hydrochloride|1353859-00-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:53抑制剂CX-6258 hydrochloride|CX-6258 hydrochloride|1353859-00-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:53抑制剂Cyanine5 carboxylic acid|Cyanine5 carboxylic acid|195867-59-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:53抑制剂CX614|CX614|191744-13-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:53抑制剂CX614|CX614|191744-13-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:53抑制剂CX614|CX614|191744-13-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:53抑制剂CVT-10216|CVT-10216|1005334-57-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:53抑制剂CVT-10216|CVT-10216|1005334-57-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:53抑制剂CW-069|CW-069|1594094-64-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:53抑制剂Curculigoside B|Curculigoside B|143601-09-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:53抑制剂Curculigoside B|Curculigoside B|143601-09-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:53抑制剂Curculigoside B|Curculigoside B|143601-09-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:53抑制剂CVT-10216|CVT-10216|1005334-57-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:53抑制剂CUDC-101|CUDC-101|1012054-59-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:53抑制剂CUDC-101|CUDC-101|1012054-59-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:53抑制剂CUDC-101|CUDC-101|1012054-59-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:52抑制剂CT1812|CT1812|1802632-22-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:52抑制剂CT1812|CT1812|1802632-22-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:52抑制剂CT1812|CT1812|1802632-22-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
